DataCite
metadata only
Immune Engineering Via Differential Antigen Carriers and Co-Stimulatory Molecules
There is an increasing clinical need for vaccines capable of enhancing antigen-specific immune responses and treatments that can induce immunological tolerance toward a single antigen. Here we explore two platforms to enhance either immunization or tolerization depending upon the secondary signals i
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Entolimod, an Adjuvant for Vaccine Augmentation#623555
- Bacterial Membrane Vesicles as Versatile Platforms for Systemic and Mucosal Vaccines.#232438
- Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients#451481
- Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine#683121
- In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virus#238950
Record · ID 1361823
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive